Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Japanese labs discontinue compound for perioperative hypertension

Jan. 11, 2002

MC-1 receives FDA approval for entry into phase II

Jan. 10, 2002

Pilot study evaluates Natrecor in chronic heart failure outpatients

Jan. 10, 2002

Vertex moves new drug candidate VX-799 into development for sepsis

Jan. 10, 2002

Patients enrolling in pivotal PRIMO-CABG trial

Jan. 9, 2002

GSK will market Natrecor in Europe under new agreement with Scios

Jan. 8, 2002

IDE filed for Batimastat BiodivYsio stent; enters pivotal phase II trial

Jan. 7, 2002

Sangamo's ZFP technology used to show control of fat cell development

Jan. 7, 2002

Unexpected gene regulatory effects by probucol and BO-653

Jan. 4, 2002

Ibuprofen blocks beneficial effects of aspirin in heart attack prevention

Jan. 3, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 27, 2026.
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...